Journal of Asthma and Allergy
Volume 9, 2016 - Issue
Open access
151
Views
54
CrossRef citations to date
0
Altmetric
Review
Benralizumab: a unique IL-5 inhibitor for severe asthma
Laren D Tan1 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, School of Medicine, Loma Linda University, Loma Linda, CA, USACorrespondence[email protected]
, Jennifer M Bratt2 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, CA, USA
, Dorottya Godor3 School of Medicine, Semmelweis University, Budapest, Hungary
, Samuel Louie2 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, CA, USA
& Nicholas J Kenyon2 Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, CA, USA
Pages 71-81
|
Published online: 04 Apr 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.